These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30809738)

  • 1. A Drug Release Model Constructed by Factorial Design to Investigate the Interaction Between Host Mesoporous Silica Carriers and Drug Molecules.
    Liu T; Wang K; Jiang M; Wan L
    AAPS PharmSciTech; 2019 Feb; 20(3):126. PubMed ID: 30809738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between mesocellular foam silica carriers and model drugs constructed by central composite design.
    Liu T; Wang K; Jiang M; Wan L
    Colloids Surf B Biointerfaces; 2019 Aug; 180():221-228. PubMed ID: 31054462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.
    Zhang Y; Jiang T; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2010 Sep; 76(1):17-23. PubMed ID: 20685333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix].
    Wu QL; Quan GL; Hong Y; Wu LN; Zeng YM; Li G; Pan X; Wu CB
    Yao Xue Xue Bao; 2015 Apr; 50(4):492-9. PubMed ID: 26223134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release.
    Vialpando M; Aerts A; Persoons J; Martens J; Van Den Mooter G
    J Pharm Sci; 2011 Aug; 100(8):3411-3420. PubMed ID: 21387318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
    Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
    Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
    Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
    Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
    Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hesperidin-Amorphization and improved dissolution properties by controlled loading onto porous silica.
    Wei Q; Keck CM; Müller RH
    Int J Pharm; 2017 Feb; 518(1-2):253-263. PubMed ID: 27871833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supersaturation of poorly soluble drugs induced by mesoporous magnesium carbonate.
    Zhang P; Zardán Gómez de la Torre T; Welch K; Bergström C; Strømme M
    Eur J Pharm Sci; 2016 Oct; 93():468-74. PubMed ID: 27590126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
    Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box-Behnken design.
    Verma S; Singh SK; Verma PR; Ahsan MN
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1358-70. PubMed ID: 23879216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.